BioTechGrid

Genetics

Prima Mente Unlocks Early-Stage Alzheimer’s Diagnostics with Epigenome Model

February 17, 2026

AI biology company, Prima Mente, is on a mission to tackle one of the greatest challenges in medicine, uncovering the…

Biotechnology

Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering

February 17, 2026

Japan-based cell therapy company Innovacell is planning to end a drought of biotech IPOs on the Tokyo stock exchange next…

Biotechnology

Cyrano noses toward pivotal trial after midphase smell loss win

February 17, 2026

Cyrano Therapeutics is savoring a phase 2 victory. With the Flavor study hitting its primary endpoint, the biotech is preparing to…

Biotechnology

Compass guides psychedelic therapy to 2nd pivotal depression win, triggering approval push

February 17, 2026

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the British biotech’s share price…

Biotechnology

Sanofi points to ‘key opportunity’ for Teva-partnered IBD in long-term data

February 17, 2026

As Sanofi attempts to bounce back from a tough year of clinical readouts, the French pharma has touted longer-term phase…

Genetics

Spotlight on Organoids

February 17, 2026

Hans Clevers, MD, PhD Professor Hans Clevers, MD, PhD, is a professor at the Hubrecht Institute, which is an institute of the Royal…

Biotechnology

Gilead’s latest synthetic lethal therapy comes via $1.5B deal with China’s Genhouse

February 16, 2026

Gilead Sciences has secured another synthetic lethal therapy, handing over $80 million upfront for the global rights to a clinic-ready…

Genetics

ML‑Predicted Insulin Resistance Identified as Risk Factor in 12 Cancers

February 16, 2026

Credit: JUAN GAERTNER/SCIENCE PHOTO LIBRARY Insulin resistance—best known as a driver of diabetes and a contributor to cardiovascular, kidney, and…

Genetics

First Cell‑Type Gene Map for Alzheimer’s Built with New Analysis Method

February 16, 2026

Researchers headed by a team at the University of California, Irvine, Joe C. Wen School of Population & Public Health…

Genetics

Systematic Discovery of Molecular Glues Targets Protein Degradation in Leukemia

February 16, 2026

Molecular structure of the leukemia protein ENL in the degradation complex introduced by the molecular glue dHTC1 [Miquel Muñoz] Cells…

Prima Mente Unlocks Early-Stage Alzheimer’s Diagnostics with Epigenome Model

Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering

Cyrano noses toward pivotal trial after midphase smell loss win

Compass guides psychedelic therapy to 2nd pivotal depression win, triggering approval push

Sanofi points to ‘key opportunity’ for Teva-partnered IBD in long-term data

Spotlight on Organoids

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

Prima Mente Unlocks Early-Stage Alzheimer’s Diagnostics with Epigenome Model

Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering

Cyrano noses toward pivotal trial after midphase smell loss win

Compass guides psychedelic therapy to 2nd pivotal depression win, triggering approval push

Sanofi points to ‘key opportunity’ for Teva-partnered IBD in long-term data

Spotlight on Organoids

Gilead’s latest synthetic lethal therapy comes via $1.5B deal with China’s Genhouse

ML‑Predicted Insulin Resistance Identified as Risk Factor in 12 Cancers

First Cell‑Type Gene Map for Alzheimer’s Built with New Analysis Method

Systematic Discovery of Molecular Glues Targets Protein Degradation in Leukemia

Novocure gets FDA nod for tumor-treating electric fields targeting pancreatic cancer

FDA clears Encora Therapeutics’ wearable wrist device for essential tremor

Integra LifeSciences cuts roles as 65 staffers impacted from Princeton, N.J., site

Labcorp launches Roche’s FDA-cleared Alzheimer’s blood test